OXYGENTA PHARMACEUTICAL LIMITE Share Price

₹ 47.05

+₹0.05 (0.11%)
1D
Last updated 03 Nov, 2026, 14:35 IST
BSE: 524636
|
Pharmaceuticals

OXYGENTA PHARMACEUTICAL LIMITE Share Price Today

As of 4 Nov 2026, OXYGENTA PHARMACEUTICAL LIMITE share price is ₹47.05. The stock opened at ₹48.48, compared to its previous close of ₹47.00. During today's trading session, OXYGENTA PHARMACEUTICAL LIMITE share price moved in the range of ₹47.00 to ₹49.30, with an average price of ₹48.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹43.00 and a high of ₹71.59.

Share price over the last 1 day fell from 47.36 to 47.05, ranging between 46.81 and 49.30.
₹47.00
0.11% up today
₹49.30
1D LOW
1D HIGH

OXYGENTA PHARMACEUTICAL LIMITE Stock Insights

Stock Performance
OutperformingBeat Nifty by 0.61 % in last 3 month
OXYGENTA PHARMACEUTICAL LIMITE stock performance
Open₹48.48
High₹49.30
Low₹47.00
Prev. close₹47.00
OXYGENTA PHARMACEUTICAL LIMITE trading activity
Volume12,070
Average traded price₹48.69
Last traded time02:35:40 03 Nov
Last traded quantity1
Circuit
L
H
₹44.65
₹49.35
52-week
L
H
₹43.00
₹71.59
Mkt Cap Cr
173.82
P/E
-12.81
P/B
-4.19
ROA
-11.34%
ROE
41.16%
ROCE
-26.02%
Quick Ratio
0.26
EV/EBITDA
-36.02

Based on fundamentals, this stock's

Performance: 3 out of 5, Neutral
Performance
Neutral
Oxygenta Pharma performance is moderate compared to markets
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Oxygenta Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

OXYGENTA PHARMACEUTICAL LIMITE Company Background

ISIN
INE102E01018
Sector Market Cap
₹ 173.82 Cr

Oxygenta Pharmaceutical Limited is an India-based company engaged in the manufacturing and selling of pharmaceutical, medical and veterinary preparations. It operates in the pharmaceutical segment. The Company also sells the products to its related companies engaged in the manufacture of formulations. Its active pharmaceutical ingredients (API) products include pantoprazole sodium, vildagliptin, telmisartan, lacosamide, and sertraline hydrochloride. The Company’s chemical products include 3-Amino-1-adamantanol, (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile, 2-N-Propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole, Isobutyramide, 4-Aminobenzonitrile, Valeronitrile and others. Its manufacturing facilities are situated at Sadasivapet Mandal, Sangareddy District, Telangana State.

OXYGENTA PHARMACEUTICAL LIMITE Financial Highlights

  • Revenue: OXYGENTA PHARMACEUTICAL LIMITE reported revenue of ₹113.27 crore in FY26 vs ₹110.61 crore in FY25. It showed an increase of 2.40% on a yearly basis.
  • Operating Profit: OXYGENTA PHARMACEUTICAL LIMITE reported an operating loss of ₹22.18 crore in FY26 vs ₹14.35 crore in FY25. It showed a decrease of 54.56% on a year-on-year basis.
  • Net Profit: OXYGENTA PHARMACEUTICAL LIMITE reported a net loss of ₹17.57 crore in FY26 vs ₹10.30 crore in FY25. It showed a decrease of 70.58% on a yearly basis.

OXYGENTA PHARMACEUTICAL LIMITE Quarterly Result Highlights

  • OXYGENTA PHARMACEUTICAL LIMITE reported revenue of ₹37.02 crore in Jun 2026, compared with ₹49.78 crore in Mar 2026, representing a decrease of 25.63% on a quarter-on-quarter (QoQ) basis.
  • OXYGENTA PHARMACEUTICAL LIMITE reported an operating loss of ₹2.51 crore in Jun 2026, compared with ₹1.28 crore in Mar 2026, representing a decrease of 96.09% on a quarter-on-quarter (QoQ) basis.
  • OXYGENTA PHARMACEUTICAL LIMITE reported a loss of ₹2.10 crore in Jun 2026, compared with ₹1.70 crore in Mar 2026, reflecting a decrease of 23.53% on a QoQ basis.
  • The earnings per share (EPS) of OXYGENTA PHARMACEUTICAL LIMITE stood at ₹4.75 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
56.54%
FII
0.00%
Other DII
0.00%
Retail and other
43.44%
Mutual funds
0.03%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

OXYGENTA PHARMACEUTICAL LIMITE Investment Returns

1 day
+0.11%
1 week
+0.60%
1 month
-1.98%
1 year
-27.47%
3 years
+59.06%
5 years
+40.03%

OXYGENTA PHARMACEUTICAL LIMITE Share Price History

OXYGENTA PHARMACEUTICAL LIMITE share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹48.48 / ₹47.05
+0.11%
02 Nov 26
₹45.16 / ₹47.00
-0.86%
30 Oct 26
₹47.01 / ₹47.41
-0.94%
29 Oct 26
₹48.44 / ₹47.86
-0.21%
Show more

OXYGENTA PHARMACEUTICAL LIMITE Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹112.98₹109.30₹39.64₹30.99
Other Income₹0.29₹1.31₹0.04₹0.02
Total Revenue₹113.27₹110.61₹39.68₹31.01
Total Expenses₹135.45₹124.96₹53.59₹41.64
Profit Before Tax-₹22.18-₹14.35-₹13.87-₹11.37
Tax-₹4.61-₹4.05-₹10.39₹0.20
Profit After Tax-₹17.57-₹10.30-₹3.48-₹11.57
EPS - Basic-₹4.75-₹2.86-₹1.09-₹8.15
EPS - Diluted-₹4.75-₹2.86-₹1.04-₹8.15

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹22.18-₹14.35-₹13.87-₹11.37
Income before WC changes-₹14.15-₹7.75-₹9.56-₹7.84
Change in Assets-₹19.41-₹7.63₹1.25-₹15.54
Change in Liabilities₹5.65₹18.21-₹4.73₹21.75
Change in WC-₹13.76₹10.58-₹3.49₹6.20
Cash flow from Operations-₹27.75₹2.83-₹13.05-₹1.63
Cash flow from Investing-₹14.39-₹11.32-₹4.09-₹9.64
Cash flow from Financing₹42.56₹8.49₹17.13₹11.22
Total Cash Flow₹0.42₹0.00-₹0.01-₹0.05
Cash (Start of the year)₹0.00₹0.00₹0.11₹0.16
Cash (End of the year)₹0.42₹0.00₹0.10₹0.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹68.25₹51.86₹39.09₹29.26
Current Assets₹51.43₹30.94₹24.11₹25.01
Total Assets₹119.68₹82.80₹63.19₹54.26
Current Liabilities₹86.10₹85.85₹33.70₹32.90
Net Current Asset-₹34.67-₹54.90-₹9.59-₹7.89
Non-Current Liabilities₹76.27₹22.60₹49.62₹67.57
Equity Capital-₹42.69-₹25.64-₹20.12-₹46.20
Total Equity & Liabilities₹119.68₹82.80₹63.19₹54.26
* All values are in INR Crore
OXYGENTA PHARMACEUTICAL LIMITE market depth
Bid quantityBid priceAsk priceAsk quantity
55547.200
4947.1400
0000
0000
0000
Total bid quantity604
Total ask quantity0
OXYGENTA PHARMACEUTICAL LIMITE technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
42.58
Neutral
ATR (14)
1.89
Neutral
STOCH(9,6)
48.17
Neutral
STOCH RSI (14)
72.73
Neutral
ADX(9)
22.46
Bearish
UO(9)
45.76
Neutral
ROC(12)
-0.17
Bearish
WillR(14)
-54.23
Neutral
Period
Simple value
Exponential vaue
5D
47.4
47.32
10D
47.19
47.34
20D
47.33
47.89
50D
51.59
50.06
100D
51.58
51.29
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

OXYGENTA PHARMACEUTICAL LIMITE
Pharmaceuticals
Add Stock
Add Another

OXYGENTA PHARMACEUTICAL LIMITE Returns Calculator

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

OXYGENTA PHARMACEUTICAL LIMITE Share Price FAQs

Please be aware that OXYGENTA PHARMACEUTICAL LIMITE stock prices are subject to continuous fluctuations due to various factors.